HER2 Support Group Forums - View Single Post - Acceleron presents RAP-661 preclinical data in osteopenic mice at International meeti

News · 05-09-2011, 10:11 PM

Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases, presented preclinical data highlighting the significant anabolic bone effects in normal and osteopenic mice of RAP-661.

More...

05-09-2011, 10:11 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,103	Acceleron presents RAP-661 preclinical data in osteopenic mice at International meeti Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases, presented preclinical data highlighting the significant anabolic bone effects in normal and osteopenic mice of RAP-661. More...